共 103 条
[1]
Zethraeus N(2007)Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model Osteoporos Int 18 9-23
[2]
Borgstrom F(2002)Models for assessing the cost-effectiveness of the treatment and prevention of osteoporosis Osteoporos Int 13 841-857
[3]
Strom O(2006)Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature Osteoporos Int 17 29-40
[4]
Kanis JA(2004)Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial JAMA 291 1701-1712
[5]
Zethraeus N(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial JAMA 288 321-333
[6]
Ben Sedrine W(2005)Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the Women’s Health Initiative randomized controlled trial Int J Technol Assess Health Care 21 433-441
[7]
Caulin F(2006)Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial JAMA 296 2927-2938
[8]
Corcaud S(2002)Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial Ann Intern Med 137 875-883
[9]
Fleurence RL(2004)Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995 Atheroscler Suppl 5 91-97
[10]
Iglesias CP(1993)Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease Arch Intern Med 153 578-581